Vivos (RDGL) Enterprise Value (QoQ) (2010 - 2025)
Vivos (RDGL) Enterprise Value (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.23% |
| Sep 30, 2025 | 17.23% |
| Jun 30, 2025 | 18.51% |
| Mar 31, 2025 | -47.57% |
| Dec 31, 2024 | -81.63% |
| Sep 30, 2024 | 29.36% |
| Jun 30, 2024 | -25.79% |
| Mar 31, 2024 | 13.91% |
| Dec 31, 2023 | -3.61% |
| Sep 30, 2023 | 12.12% |
| Jun 30, 2023 | -23.81% |
| Mar 31, 2023 | 17.21% |
| Dec 31, 2022 | 14.17% |
| Sep 30, 2022 | -89.18% |
| Jun 30, 2022 | 14.01% |
| Mar 31, 2022 | 23.93% |
| Dec 31, 2021 | 19.15% |
| Sep 30, 2021 | 8.23% |
| Jun 30, 2021 | 13.82% |
| Mar 31, 2021 | -177.95% |